Anagenics Ltd
Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pac… Read more
Anagenics Ltd (AN1) - Total Assets
Latest total assets as of December 2025: AU$4.10 Million AUD
Based on the latest financial reports, Anagenics Ltd (AN1) holds total assets worth AU$4.10 Million AUD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Anagenics Ltd - Total Assets Trend (2006–2025)
This chart illustrates how Anagenics Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Anagenics Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Anagenics Ltd's total assets of AU$4.10 Million consist of 47.3% current assets and 52.8% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$395.52K | 9.6% |
| Accounts Receivable | AU$574.85K | 14.0% |
| Inventory | AU$967.72K | 23.6% |
| Property, Plant & Equipment | AU$211.20K | 5.2% |
| Intangible Assets | AU$1.44K | 0.0% |
| Goodwill | AU$1.95 Million | 47.6% |
Asset Composition Trend (2006–2025)
This chart illustrates how Anagenics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anagenics Ltd's current assets represent 47.3% of total assets in 2025, a decrease from 50.1% in 2006.
- Cash Position: Cash and equivalents constituted 9.6% of total assets in 2025, down from 40.8% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, a decrease from 48.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 47.6% of total assets.
Anagenics Ltd Competitors by Total Assets
Key competitors of Anagenics Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
Anagenics Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Anagenics Ltd generates 1.16x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Anagenics Ltd is currently not profitable relative to its asset base.
Anagenics Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.10 | 1.08 | 3.43 |
| Quick Ratio | 0.56 | 0.53 | 2.49 |
| Cash Ratio | 0.00 | 0.25 | 1.96 |
| Working Capital | AU$190.81K | AU$ 158.12K | AU$ 5.64 Million |
Anagenics Ltd - Advanced Valuation Insights
This section examines the relationship between Anagenics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.04 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -33.8% |
| Total Assets | AU$4.10 Million |
| Market Capitalization | $738.39K USD |
Valuation Analysis
Below Book Valuation: The market values Anagenics Ltd's assets below their book value (0.18 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Anagenics Ltd's assets decreased by 33.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Anagenics Ltd (2006–2025)
The table below shows the annual total assets of Anagenics Ltd from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$4.10 Million | -33.76% |
| 2024-06-30 | AU$6.19 Million | -44.28% |
| 2023-06-30 | AU$11.11 Million | -14.02% |
| 2022-06-30 | AU$12.92 Million | -2.77% |
| 2021-06-30 | AU$13.29 Million | -10.71% |
| 2020-06-30 | AU$14.89 Million | +52.04% |
| 2019-06-30 | AU$9.79 Million | +45.10% |
| 2018-06-30 | AU$6.75 Million | -20.35% |
| 2017-06-30 | AU$8.47 Million | +14.26% |
| 2016-06-30 | AU$7.41 Million | +20.61% |
| 2015-06-30 | AU$6.15 Million | -4.75% |
| 2014-06-30 | AU$6.45 Million | +7.69% |
| 2013-06-30 | AU$5.99 Million | +138.01% |
| 2012-06-30 | AU$2.52 Million | -10.76% |
| 2011-06-30 | AU$2.82 Million | -12.32% |
| 2010-06-30 | AU$3.22 Million | +163.26% |
| 2009-06-30 | AU$1.22 Million | -53.01% |
| 2008-06-30 | AU$2.60 Million | -44.83% |
| 2007-06-30 | AU$4.72 Million | -22.89% |
| 2006-06-30 | AU$6.11 Million | -- |